Post-earnings recap
Reported
Thu, Jan 29, 2026
EPS actual
$2.81
EPS est.
$2.69
EPS surprise
+4.58%
1-day move
-0.04%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ResMed's earnings report showed a positive surprise in EPS, which indicates better-than-expected profitability. However, the stock experienced a slight decline of 0.04%, suggesting that investors may have been looking for more comprehensive revenue details or future guidance. The lack of revenue figures and guidance may have contributed to the muted stock reaction.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.81 | N/A | +4.58% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. However, they did not provide specific guidance for future quarters.
We are pleased with our EPS performance this quarter.
Our focus remains on innovation and meeting customer needs.